Private insurers are now required to provide HIV prevention drugs (commonly referred to as pre-exposure prophylaxis or PrEP) to policyholders at no cost after a recommendation by the U.S. Preventative Task Force (“Task Force”).
Under the Affordable Care Act, insurers are required to provide certain preventative services at no cost if the Task Force assigns a service with an “A” or “B” rating. On June 11, 2020, the Task Force assigned PrEP with an “A” recommendation for individuals who are at high risk of HIV in the Journal of the American Medical Association. This means that individuals with employer-sponsored insurance will no longer need to pay any deductibles, co-pays, or co-insurance for PrEP medication.
The new coverage requirement will apply to plans that are renewed or issued after the Task Force’s recommendation (for the 2021 plan year). Although plans are not required to offer the coverage for free until their plans are renewed after June 11, 2020, California’s Insurance Commissioner released a notice that encouraged insurers to provide PrEP without cost-sharing as soon as possible.
The information and materials on this blog are provided for informational purposes only and are not intended to constitute legal or tax advice. Information provided in this blog may not reflect the most current legal developments and may vary by jurisdiction. The content on this blog is for general informational purposes only and does not apply to any particular facts or circumstances. The use of this blog does not in any way establish an attorney-client relationship, nor should any such relationship be implied, and the contents do not constitute legal or tax advice. If you require legal or tax advice, please consult with a licensed attorney or tax professional in your jurisdiction. The contributing authors expressly disclaim all liability to any persons or entities with respect to any action or inaction based on the contents of this blog.
